Skip to main content
. 2019 Dec 18;12(1):4. doi: 10.3390/cancers12010004

Table 3.

Analysis of the possibility of different mitochondria-targeted molecules to be available for the practical application.

No. Molecular Design Barrier for Practical Application Advantages for Practical Application
1 Conventional drug conjugate with mitochondria targeting ligand Fetal toxicity and side effects -
2 Protein inhibitor conjugate with mitochondria targeting ligand Complicated synthetic procedure, acquired resistance High tumor selectivity
3 Mitochondria penetrating peptide conjugate with cargo Complicated molecular design, needs to carry a cargo. -
4 Mitochondria-targeted drug-free agents - Work at small concertation, ease of production, high selectivity towards the tumor, fewer side effects.